AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GEIGER COUNTER LIMITED

Regulatory Filings Apr 3, 2024

7665_rns_2024-04-03_d2a01e18-f678-467c-bcfe-b84b852b7229.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0260J

Geiger Counter Ltd

03 April 2024

3 April 2024

GEIGER COUNTER LIMITED

(THE "COMPANY")

Investment Manager

Geiger Counter Limited announces that, further to the RNS announcement previously made on 15 November 2023, its Investment Manager and AIFM, CQS (UK) LLP, has advised that the acquisition by Manulife Investment Management, a leading international financial services group, has now closed.  There are no planned changes to the investment management team and the Board look forward to working with the new group.

As part of the transaction, Manulife Investment Management has acquired the CQS brand and intends to align it with the Manulife brand as a co-branded logo.

Enquiries

Manulife|CQS Craig Cleland T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited Tunga Chigovanyika/ Will Talkington (Corporate Finance) T: +44 (0) 20 7220 0557
Daniel Balabanoff / Pauline Tribe (Sales) T: +44 (0) 20 7220 0500
R&H Fund Services (Jersey) Limited Jane De Barros T :+44 (0) 1534 825 259

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPUPUMACUPCGCP

Talk to a Data Expert

Have a question? We'll get back to you promptly.